Alinity i Hepatitis B Surface Antigen 2 CLIA Non-Waived Reagent - 200 Tests

This comprehensive 200-test kit provides reliable qualitative detection of hepatitis B surface antigen (HBsAg) for clinical laboratory use. Designed specifically for the Alinity i analyzer, this chemiluminescent microparticle immunoassay (CMIA) reagent delivers accurate results for hepatitis B screening and diagnosis.

Advanced Diagnostic Capabilities

The Alinity i HBsAg Qualitative II assay is engineered for precision testing across diverse patient populations. This CLIA non-waived reagent supports comprehensive hepatitis B screening programs in clinical laboratory settings.

Sample Compatibility

Compatible with human adult and pediatric serum and plasma samples, as well as neonate serum specimens. This versatility ensures comprehensive testing capabilities for various patient demographics and clinical scenarios.

Clinical Applications

• Qualitative detection of hepatitis B surface antigen (HBsAg)
• Screening for HBV infection in pregnant women
• Identification of neonates at risk for perinatal hepatitis B transmission
• General hepatitis B infection screening and diagnosis

Each kit contains essential components including microparticles, conjugate, and ancillary wash buffer, all designed for optimal performance on the Alinity i analyzer platform. The reagent requires proper refrigeration storage to maintain stability and ensure consistent, reliable results throughout its shelf life.